首页|期刊导航|中华骨质疏松和骨矿盐疾病杂志|北京地区血清25羟维生素D水平与甲状腺乳头状癌发生风险的相关性研究

北京地区血清25羟维生素D水平与甲状腺乳头状癌发生风险的相关性研究OA

Correlation between serum 25-hydroxyvitamin D levels and the risk of papillary thyroid carcinoma in Beijing

中文摘要英文摘要

目的 在北京地区人群中,探讨甲状腺乳头状癌组和非甲状腺癌组血清 25 羟维生素 D[25-hydroxyvitamin D,25(OH)D]水平、甲状腺激素敏感性指数与甲状腺乳头状癌发生风险的相关性.方法 选取经甲状腺手术病理诊断为甲状腺乳头状癌患者 226 例为病例组,经超声筛查甲状腺结构(正常无甲状腺结节)者 218 例为对照组.比较两组间临床资料、血清25(OH)D水平、甲状腺激素敏感性指数与甲状腺乳头状癌分布情况,行血清25(OH)D水平、甲状腺激素敏感性指数与甲状腺乳头状癌的相关性分析、风险回归分析及建立风险限制立方样条模型.结果 病例组25(OH)D显著低于对照组[(17.79±5.08)vs.(21.47±4.51)ng/mL,P<0.001];25(OH)D四分位分组与甲状腺乳头状癌呈显著性负相关,且趋势性检验显著(P=0.038);限制性立方样条回归分析(restricted cubic spline,RCS)结果显示,25(OH)D与甲状腺乳头状癌有显著的倒"U"型非线性趋势(P=0.021),且在校正性别、年龄、体质量指数等混杂因素后,该关联仍然显著(P<0.001).本研究人群中血清25(OH)D对甲状腺乳头状癌的区分能力较好,基于约登指数得到的最佳截断值为 18.95 ng/mL,在此阈值下,灵敏度约 90%,特异度约 76%.在全部人群及甲状腺乳头状癌患者中,血清25(OH)D与甲状腺激素及其敏感性指数均不存在显著性相关性;无论是否校正混杂因素,甲状腺激素敏感性指数[甲状腺反馈分位数指数(thyroid feedback quantile-based index,TFQI)、促甲状腺激素指数(thyroid stimulating hormone index,TSHI)、促甲状腺激素 T4 抵抗指数(thyroid stimulating hormone cell-T4 resistance index,TT4RI)、游离甲状腺素/游离三碘甲状腺原氨酸(the ratio of free thyroxine to free triiodothyro-nine,FT4/FT3)]与甲状腺乳头状癌发生风险均无显著关联;RCS 模型显示 FT4/FT3、TFQI、TSHI、TT4RI与甲状腺乳头状癌发生风险呈倒"U"型关系,但该关联均不显著(P>0.05).结论 北京地区人群血清25(OH)D水平与甲状腺乳头状癌呈显著负相关且存在倒"U"型非线性关系,其最佳截断值为 18.95 ng/mL,低于该水平甲状腺乳头状癌的发生风险升高.甲状腺激素、甲状腺相关抗体及敏感性指数与甲状腺乳头状癌无显著关联.

Objective To investigate the association between serum 25-hydroxyvitamin D[25(OH)D]levels and thyroid hormone sensitivity indexes and the risk of papillary thyroid carcinoma in Beijing population.Methods A total of 226 patients with pathologically confirmed papillary thyroid carcinoma after thyroid surgery were enrolled as the case group.The control group consisted of 218 individuals with normal thyroid structure and no thyroid nodules in ultra-sonographic screening.The clinical data,serum 25(OH)D,thyroid hormone sensitivity indexes and distribution of pa-pillary thyroid carcinoma were compared between the two groups.Correlation analysis,risk regression analysis and re-stricted cubic spline risk(RCS)model construction were performed to explore the associations of serum 25-hydroxyvita-min D levels and thyroid hormone sensitivity index with papillary thyroid carcinoma.Results The levels of 25(OH)D in the case group were significantly lower than that in the control group[(17.79±5.08)vs.(21.47±4.51)ng/mL,P<0.001].The quartile grouping of 25(OH)D showed a significant negative correlation with papillary thyroid carci-noma,and the trend test was significant(P=0.038).The results of RCS regression analysis indicated a significant inverted"U-shaped"nonlinear trend between 25(OH)D and papillary thyroid carcinoma(P=0.021),and this association remained significant after adjusted for confounding factors including gender,age and body mass index(P<0.001).The serum 25(OH)D in this population had a good discriminatory ability for papillary thyroid carcino-ma.The optimal cut-off value based on Youden's index was 18.95 ng/mL.At this threshold,the sensitivity was ap-proximately 90%and the specificity was approximately 76%.There was no association between 25(OH)D and thy-roid hormone sensitivity indices in both total population and mere patients with papillary thyroid carcinoma.There was no significant association between thyroid hormone sensitivity indices including the thyroid feedback quantile-based index(TFQI),thyroid stimulating hormone index(TSHI),thyroid stimulating hormone cell-T4 resistance index(TT4RI)and the ratio of free thyroxine to free triiodothyronine(FT4/FT3)and the risk of papillary thyroid carcino-ma.The RCS model showed an inverted"U-shaped"relationship between FT4/FT3,TFQI,TSHI,TT4RI and the risk of papillary thyroid carcinoma,but none of these associations were significant(P>0.05).Conclusion Serum 25(OH)D levels are significantly and negatively associated with papillary thyroid carcinoma in Beijing population,with an inverted"U-shaped"nonlinear relationship.The optimal cutoff value of 25(OH)D for papillary thyroid car-cinoma risk stratification is 18.95 ng/mL,below which the risk of papillary thyroid carcinoma significantly increases.No significant correlations are observed between thyroid hormones,and thyroid-associated antibodies and sensitivity indices and papillary thyroid carcinoma.

周美岑;邓微;兰玲;徐雪迎;王静;陈佳;霍丽丽;王志新;边南南;徐晓杰

100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科100035 北京,首都医科大学附属北京积水潭医院内分泌科

医药卫生

25羟维生素D甲状腺乳头状癌甲状腺激素甲状腺相关抗体甲状腺激素敏感性指数

25-hydroxyvitamin Dpapillary thyroid carcinomathyroid hormonethyroid related antibodythy-roid hormone sensitivity index

《中华骨质疏松和骨矿盐疾病杂志》 2026 (4)

473-482,10

北京积水潭医院高层次人才学科骨干培养计划(XKGG202119)

10.3969/j.issn.1674-2591.2026.04.006

评论